arrow_back Back Filing freshness 20-F FY 2025 SEC EDGAR

111, Inc.

YI
$4.00 ▲ +0.21 (+5.54%) at close
Healthcare ·Retail-Drug Stores and Proprietary Stores ·USRetail-Drug Stores and Proprietary Stores
8 Visible periods
30 Metrics
Peer-ranked Benchmarks
Price Chart
43
Health
Weak
Bullish
auto_awesome

Analytical Summary

111, Inc. shows strong fundamentals with top-quartile Debt to Equity. The company's metrics support a bullish outlook for growth-oriented investors.

Market Cap $696.1M
Dividend Yield
Revenue Growth -9.0%
Op. Margin -0.0%
ROIC 0.3%
FCF / Share $0.09
Trailing P/E
Price / Book
FCF Yield 2.4%
Debt / Equity -0.27
info Valuation on last close. End-of-day price, Aug 7, 2026.

8-Year Financial Trajectory

Annual
Metric Value Trend Year over Year Percentile
Revenue Total top-line sales
$1.80B
↓ -9.0%
Net Income Profit after all expenses
$-3.22M
↓ -13.1%
Operating Margin Operating profit as % of sales
-0.0%
↓ -229.3% 28th
FCF / Share Free cash flow per share
$0.09
↓ -52.3%
trending_up

Bullish Indicators

  • Debt to EquityDebt to Equity is in the top quartile (lower is better)
warning

Bearish Risks

  • No bearish risks detected.

Health Breakdown

Profitability
29
Returns
50
Financial Health
72
Cash Quality
3

bar_chart Data from SEC EDGAR XBRL filings

Synced 1 week ago 8 years · 8 quarters